Article Details
Retrieved on: 2022-05-07 15:36:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm currently has $2.75 target price on the biopharmaceutical company's stock. According to Zacks, “Arbutus Biopharma Corporation is a ...
Article found on: www.kopsource.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here